Ngā hua rapu - Labianca, Roberto
- E whakaatu ana i te 1 - 20 hua o te 36
- Haere ki te Whārangi Whai Ake
-
1
-
2
Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer mā Heinemann, Volker, Boeck, Stefan, Hinke, Axel, Labianca, Roberto, Louvet, Christophe
I whakaputaina 2008Text -
3
-
4
Pain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients mā Apolone, Giovanni, Bertetto, Oscar, Caraceni, Augusto, Corli, Oscar, De Conno, Franco, Labianca, Roberto, Maltoni, Marco, Nicora, Mariaflavia, Torri, Valter, Zucco, Furio
I whakaputaina 2006Text -
5
Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study mā Barni, Sandro, Labianca, Roberto, Agnelli, Giancarlo, Bonizzoni, Erminio, Verso, Melina, Mandalà, Mario, Brighenti, Matteo, Petrelli, Fausto, Bianchini, Carlo, Perrone, Tania, Gasparini, Giampietro
I whakaputaina 2011Text -
6
Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial mā Guida, Michele, Ravaioli, Alessandra, Sileni, Vanna Chiarion, Romanini, Antonella, Labianca, Roberto, Freschi, Antonio, Brugnara, Salvatore, Casamassima, Addolorata, Lorusso, Vito, Nanni, Oriana, Ridolfi, Ruggero
I whakaputaina 2003Text -
7
Association of Socioeconomic Status With Breslow Thickness and Disease-Free and Overall Survival in Stage I-II Primary Cutaneous Melanoma mā Mandalà, Mario, Imberti, Gian Lorenzo, Piazzalunga, Dario, Belfiglio, Maurizio, Lucisano, Giuseppe, Labianca, Roberto, Marchesi, Lorenzo, Merelli, Barbara, Robone, Silvana, Poletti, Paola, Milesi, Laura, Tondini, Carlo
I whakaputaina 2011Text -
8
Benefits and Adverse Events in Younger Versus Older Patients Receiving Adjuvant Chemotherapy for Colon Cancer: Findings From the Adjuvant Colon Cancer Endpoints Data Set mā Hubbard, Joleen, Thomas, David M., Yothers, Greg, Green, Erin, Blanke, Charles, O'Connell, Michael J., Labianca, Roberto, Shi, Qian, Bleyer, Archie, de Gramont, Aimery, Sargent, Daniel
I whakaputaina 2012Text -
9
DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy mā Sinicrope, Frank A., Foster, Nathan R., Thibodeau, Stephen N., Marsoni, Silvia, Monges, Genevieve, Labianca, Roberto, Yothers, Greg, Allegra, Carmen, Moore, Malcolm J., Gallinger, Steven, Sargent, Daniel J.
I whakaputaina 2011Text -
10
Body Mass Index at Diagnosis and Survival Among Colon Cancer Patients Enrolled in Clinical Trials of Adjuvant Chemotherapy mā Sinicrope, Frank A., Foster, Nathan R., Yothers, Greg, Benson, Al, Seitz, Jean Francois, Labianca, Roberto, Goldberg, Richard M., DeGramont, Aimery, O’Connell, Michael J., Sargent, Daniel J.
I whakaputaina 2013Text -
11
The IDEA Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX Regimen for Patients with Stage III Colon Cance... mā Meyerhardt, Jeffrey A., Sargent, Daniel, Paul, James, Sobrero, Alberto, André, Thierry, Shields, Anthony F., Yoshino, Takayuki, Souglakos, Ioannis, Iveson, Timothy, Labianca, Roberto, Taieb, Julien, Ohtsu, Atsushi, Grothey, Axel
I whakaputaina 2014Text -
12
The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy wi... mā André, Thierry, Iveson, Timothy, Labianca, Roberto, Meyerhardt, Jeffrey A., Souglakos, Ioannis, Yoshino, Takayuki, Paul, James, Sobrero, Alberto, Taieb, Julien, Shields, Anthony F., Ohtsu, Atsushi, Grothey, Axel, Sargent, Daniel J.
I whakaputaina 2013Text -
13
ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer mā Renfro, Lindsay A., Grothey, Axel, Xue, Yuan, Saltz, Leonard B., André, Thierry, Twelves, Chris, Labianca, Roberto, Allegra, Carmen J., Alberts, Steven R., Loprinzi, Charles L., Yothers, Greg, Sargent, Daniel J.
I whakaputaina 2014Text -
14
Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in sit... mā Scartozzi, Mario, Bearzi, Italo, Mandolesi, Alessandra, Pierantoni, Chiara, Loupakis, Fotios, Zaniboni, Alberto, Negri, Francesca, Quadri, Antonello, Zorzi, Fausto, Galizia, Eva, Berardi, Rossana, Biscotti, Tommasina, Labianca, Roberto, Masi, Gianluca, Falcone, Alfredo, Cascinu, Stefano
I whakaputaina 2009Text -
15
Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials mā Sargent, Daniel, Sobrero, Alberto, Grothey, Axel, O'Connell, Michael J., Buyse, Marc, Andre, Thierry, Zheng, Yan, Green, Erin, Labianca, Roberto, O'Callaghan, Chris, Seitz, Jean Francois, Francini, Guido, Haller, Daniel, Yothers, Greg, Goldberg, Richard, de Gramont, Aimery
I whakaputaina 2009Text -
16
Validity of Adjuvant! Online in Older Patients with Stage III Colon Cancer Based on 2,967 Patients from the ACCENT Database mā Papamichael, Demetris, Renfro, Lindsay A., Matthaiou, Christiana, Yothers, Greg, Saltz, Leonard, Guthrie, Katherine, Van Cutsem, Eric, Schmoll, Hans-Joachim, Labianca, Roberto, André, Thierry, O’Connell, Michael, Alberts, Steven R., Haller, Daniel G., Kountourakis, Panteleimon, Sargent, Daniel J.
I whakaputaina 2016Text -
17
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the S... mā Giampieri, Riccardo, Puzzoni, Marco, Daniele, Bruno, Ferrari, Daris, Lonardi, Sara, Zaniboni, Alberto, Cavanna, Luigi, Rosati, Gerardo, Pella, Nicoletta, Zampino, Maria Giulia, Sozzi, Pietro, Germano, Domenico, Zagonel, Vittorina, Codecà, Carla, Libertini, Michela, Labianca, Roberto, Cascinu, Stefano, Scartozzi, Mario
I whakaputaina 2017Text -
18
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer mā Sargent, Daniel J., Marsoni, Silvia, Monges, Genevieve, Thibodeau, Stephen N., Labianca, Roberto, Hamilton, Stanley R., French, Amy J., Kabat, Brian, Foster, Nathan R., Torri, Valter, Ribic, Christine, Grothey, Axel, Moore, Malcolm, Zaniboni, Alberto, Seitz, Jean-Francois, Sinicrope, Frank, Gallinger, Steven
I whakaputaina 2010Text -
19
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phas... mā André, Thierry, Meyerhardt, Jeffrey, Iveson, Timothy, Sobrero, Alberto, Yoshino, Takayuki, Souglakos, Ioannis, Grothey, Axel, Niedzwiecki, Donna, Saunders, Mark, Labianca, Roberto, Yamanaka, Takeharu, Boukovinas, Ioannis, Vernerey, Dewi, Meyers, Jeffrey, Harkin, Andrea, Torri, Valter, Oki, Eiji, Georgoulias, Vassilis, Taieb, Julien, Shields, Anthony, Shi, Qian
I whakaputaina 2020Text -
20
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database mā Cheung, Winson Y., Renfro, Lindsay A., Kerr, David, de Gramont, Aimery, Saltz, Leonard B., Grothey, Axel, Alberts, Steven R., Andre, Thierry, Guthrie, Katherine A., Labianca, Roberto, Francini, Guido, Seitz, Jean-Francois, O’Callaghan, Chris, Twelves, Chris, Van Cutsem, Eric, Haller, Daniel G., Yothers, Greg, Sargent, Daniel J.
I whakaputaina 2016Text